Literature DB >> 8961900

Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis.

R J Dolhain1, A N van der Heiden, N T ter Haar, F C Breedveld, A M Miltenburg.   

Abstract

OBJECTIVE: To investigate whether T cells in the inflamed joints of patients with rheumatoid arthritis (RA) preferentially produce the T helper 1 (Th1) cytokines, interferon-gamma (IFN gamma) and interleukin-2 (IL-2), or the Th2 cytokine, IL-4, when compared with corresponding peripheral blood-derived T cells.
METHODS: Synovial fluid mononuclear cells (SFMC) and corresponding peripheral blood mononuclear cells (PBMC) from 10 patients with RA were analyzed, either directly or after in vitro stimulation, for the intracellular presence of Th1 and Th2 cytokines. The amount of secreted cytokine in the cell culture supernatants was measured by enzyme-linked immunosorbent assay (ELISA).
RESULTS: IFN gamma-containing cells were detected in the unstimulated SFMC, but not in the PBMC, of 3 patients with RA. Cells positive for IL-2 or IL-4 were not detected in the unstimulated samples. Following stimulation, the mean percentage of cells containing Th1 cytokines was significantly increased in the SFMC compared with the PBMC; no differences were found in the mean percentage of IL-4-containing cells. A comparable shift toward Th1 cytokines was observed when the amount of secreted cytokine was determined by ELISA.
CONCLUSION: A shift toward T cells with a Th1 cytokine profile was observed in the joints of patients with RA. Since an imbalance between Th1 and Th2 cells is thought to be of pathogenic significance, this finding might have implications for the development of new therapies for RA.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8961900     DOI: 10.1002/art.1780391204

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  72 in total

Review 1.  Human CD4+ T cell differentiation and effector function: implications for autoimmunity.

Authors:  L S Davis; H Schulze-Koops; P E Lipsky
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 2.  Th2 mediated regulation in RA and the spondyloarthropathies.

Authors:  J A G van Roon; J W J Bijlsma
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

3.  Mucosal anti-CD3 monoclonal antibody attenuates collagen-induced arthritis that is associated with induction of LAP+ regulatory T cells and is enhanced by administration of an emulsome-based Th2-skewing adjuvant.

Authors:  Henry Yim Wu; Ruth Maron; Ann-Marcia Tukpah; Howard L Weiner
Journal:  J Immunol       Date:  2010-08-18       Impact factor: 5.422

Review 4.  Adhesion molecules in rheumatoid arthritis.

Authors:  N Oppenheimer-Marks; P E Lipsky
Journal:  Springer Semin Immunopathol       Date:  1998

5.  Will the increasing prevalence of atopy have a favourable impact on rheumatoid arthritis?

Authors:  J S Gaston
Journal:  Ann Rheum Dis       Date:  1998-05       Impact factor: 19.103

6.  Simultaneous analysis of T cell clonality and cytokine production in rheumatoid arthritis using three-colour flow cytometry.

Authors:  P Bakakos; C Pickard; W M Wong; K R Ayre; J Madden; A J Frew; E Hodges; M I D Cawley; J L Smith
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

7.  In vitro differentiation of peripheral blood T cells towards a type 2 phenotype is impaired in rheumatoid arthritis (RA).

Authors:  S Asselin; H Conjeaud; D Fradelizi; M Breban
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

8.  Serum interleukin 12 concentration in juvenile chronic arthritis.

Authors:  M Gattorno; P Picco; S Vignola; F Stalla; A Buoncompagni; V Pistoia
Journal:  Ann Rheum Dis       Date:  1998-07       Impact factor: 19.103

9.  Interleukin-4 suppression of interleukin-1-induced transcription of collagenase (MMP-1) and stromelysin 1 (MMP-3) in human synovial fibroblasts.

Authors:  R C Borghaei; P L Rawlings; E Mochan
Journal:  Arthritis Rheum       Date:  1998-08

Review 10.  The IL-33/ST2 pathway: therapeutic target and novel biomarker.

Authors:  Rahul Kakkar; Richard T Lee
Journal:  Nat Rev Drug Discov       Date:  2008-10       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.